Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Bioequivalency Study of 50 mg Cilostazol Tablets Under Fasting Conditions

This study has been completed.
Information provided by:
Roxane Laboratories Identifier:
First received: January 15, 2008
Last updated: January 31, 2008
Last verified: January 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2004
  Primary Completion Date: March 2004 (Final data collection date for primary outcome measure)